Abaris Biotech.Opportunities A EUR/ LU2210105669 /
| NAV5/31/2024 | Chg.-1.0600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 64.4100EUR | -1.62% | reinvestment | Equity | Hauck & Aufhäuser ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 6/3/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 12/31/2023 | Semi-annual report | 2023 | German | 651.10 KB |
| 11/10/2023 | PRIIP Key Information Document | 2023 | German | 270.38 KB |
| 6/30/2023 | Account statment | 2023 | German | 678.51 KB |
| 1/1/2023 | Prospectus | 2023 | German | 874.24 KB |
| 7/15/2022 | Key Investor Information | 2022 | German | 104.53 KB |
